학술논문
Ezabenlimab (BI 754091), an anti-PD-1 antibody, in patients with advanced solid tumours
Document Type
Article
Author
Source
In: Cancer Immunology, Immunotherapy . (Cancer Immunology, Immunotherapy, May 2024, 73(5))
Subject
Language
English
ISSN
14320851
03407004
03407004